CD4 and neoplasm: Treatment responsive HCCs, however, responded via different immune pathways, with no significant changes observed in CD8+ or myeloid cell populations but instead a significant increase in tumour infiltrating GZB+ NK+ cells and a concomitant decrease in CD4+ T-regulatory cells.